基因重组人脑利钠肽治疗心力衰竭研究进展(2)
[1]Martin R, Gustavo F. BNP and Congrestive Heart Failure. Prog Cardiovascu Dis 2002,44(4): 293-321.
[2]Oliver P, Fox J, Kin R, et al.Hypertension. cardiac hypertrophy and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA, 1997, 94: 14730-14735.
[3]Tamura N, Ogawa Y, Chusho H, et al.Cardiac fibrosis in mice lacking brain natriuretic peptide.Proc Natl Acad Sci USA, 2000, 97: 4239-4244.
, http://www.100md.com
[4]Elmers L, Knowles J. Ventricular expression of atrial and brain natriuretic peptide in NPR-1 deficientmice with cardiac hypertrophy and fibrosis. Am J Physiol,2002, 283: 707-714.
[5]Vicky AC, Leigh J. M inireview, Natriuretic peptides during development of the fetal heart and circulation.Endocrinology,2003,144(6): 2191-2194.
[6]Surakit Nathisuwan, Robert L,Talbert A.Review of vasopeptidase inhibitors a new modality in the treament of hypertension and chronic heart failure. Pharmacotherapy, 2002, 22(1): 27-42 .
, 百拇医药
[7]Miriam TR, Richard AM. Cardiac natriuretic peptides for cardiac health. Clinical Science,2005,108: 23-36.
[8]Osman R, Alat I,Coskun S, et al.The role of brain natriuretic peptide in the prediction of cardiac performace in coronary artery bypass grafting. Tex Heart Inst J, 2003, 30: 298-304.
[9]James A, Lemos MD, David A. Morrow MD.Brain natriuretic peptide measurement in actue coronary syndrome: Ready for clinical application. Circulation, 2002,106: 2868-2870
, http://www.100md.com
[10] Roberto L, Serge M, Inder A, et al.Efects of valsartan on circulating brain natriuretic peptide an norepingphrine in symptomatic chronic heart failure. Circulation,2002,106(19):2454-2458.
[11]毛懿，杨跃进.急性心肌梗死患者血浆脑钠素水平的变化规律与预后的关系,中国循环杂志，2003,18(5)：393-395.
[12]FeilR, Lonhm ann SM, de Jonge H, et al.Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res,2003, 93(10): 907-916.
, 百拇医药
[13]Burger AI. A review of the renal and neurohomonal effects of B-type natriuretic peptide. Congest Heart Fail,2005,11(1): 30-38.
[14]Kapoun AM, Liang F, OYoung G,et al.B- type natriuretic peptide exerts broad functional opposition to transforming growth factorbeta in primary human cardiac fibroblasta fibrosis myofibroblast conversion proliferation and inflammation. Circ Res, 2004,94(1): 453-461.
[15]Wiznitaer A, Fuman B, Zuili I,et al. Cord lep tin level and fetal-macrosomia. Obstet Gynecol,2004,103(3):5191.
, http://www.100md.com
[16]Roger M,Thierry H.Sustainded hemodynamic effects of in 2 fusion of nesinitide (human B-type natriuretics peptide) in heart failure. JACC,1999,34(1):1551.
[17]谢昌联，孟素荣，王蔚,等.硝酸甘油和重组人脑利钠肽对急性失代偿性心力衰竭的疗效比较.南方医科大学学报，2008，28(5)：839-842.
[18]尤华彦，吴小庆.重组人脑利钠肽辅助治疗慢性充血性心力衰竭273例疗效观察.山东医药，2009，49(51)：69-70.
[19]马登峰，王晨，王文强.重组人脑利钠肽治疗急性心肌梗死合并并心衰疗效评价.中西医结合心脑血管病杂志，2010，8(7)：866-868.
[20]王志方,刘玲玲,刘志强.冻干重组人脑利钠肽治疗顽固性心力衰竭的疗效观察.中国医药导报，2010,5(24):61-62., http://www.100md.com(曹伟灵 陈曦宋芳)
[2]Oliver P, Fox J, Kin R, et al.Hypertension. cardiac hypertrophy and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA, 1997, 94: 14730-14735.
[3]Tamura N, Ogawa Y, Chusho H, et al.Cardiac fibrosis in mice lacking brain natriuretic peptide.Proc Natl Acad Sci USA, 2000, 97: 4239-4244.
, http://www.100md.com
[4]Elmers L, Knowles J. Ventricular expression of atrial and brain natriuretic peptide in NPR-1 deficientmice with cardiac hypertrophy and fibrosis. Am J Physiol,2002, 283: 707-714.
[5]Vicky AC, Leigh J. M inireview, Natriuretic peptides during development of the fetal heart and circulation.Endocrinology,2003,144(6): 2191-2194.
[6]Surakit Nathisuwan, Robert L,Talbert A.Review of vasopeptidase inhibitors a new modality in the treament of hypertension and chronic heart failure. Pharmacotherapy, 2002, 22(1): 27-42 .
, 百拇医药
[7]Miriam TR, Richard AM. Cardiac natriuretic peptides for cardiac health. Clinical Science,2005,108: 23-36.
[8]Osman R, Alat I,Coskun S, et al.The role of brain natriuretic peptide in the prediction of cardiac performace in coronary artery bypass grafting. Tex Heart Inst J, 2003, 30: 298-304.
[9]James A, Lemos MD, David A. Morrow MD.Brain natriuretic peptide measurement in actue coronary syndrome: Ready for clinical application. Circulation, 2002,106: 2868-2870
, http://www.100md.com
[10] Roberto L, Serge M, Inder A, et al.Efects of valsartan on circulating brain natriuretic peptide an norepingphrine in symptomatic chronic heart failure. Circulation,2002,106(19):2454-2458.
[11]毛懿，杨跃进.急性心肌梗死患者血浆脑钠素水平的变化规律与预后的关系,中国循环杂志，2003,18(5)：393-395.
[12]FeilR, Lonhm ann SM, de Jonge H, et al.Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res,2003, 93(10): 907-916.
, 百拇医药
[13]Burger AI. A review of the renal and neurohomonal effects of B-type natriuretic peptide. Congest Heart Fail,2005,11(1): 30-38.
[14]Kapoun AM, Liang F, OYoung G,et al.B- type natriuretic peptide exerts broad functional opposition to transforming growth factorbeta in primary human cardiac fibroblasta fibrosis myofibroblast conversion proliferation and inflammation. Circ Res, 2004,94(1): 453-461.
[15]Wiznitaer A, Fuman B, Zuili I,et al. Cord lep tin level and fetal-macrosomia. Obstet Gynecol,2004,103(3):5191.
, http://www.100md.com
[16]Roger M,Thierry H.Sustainded hemodynamic effects of in 2 fusion of nesinitide (human B-type natriuretics peptide) in heart failure. JACC,1999,34(1):1551.
[17]谢昌联，孟素荣，王蔚,等.硝酸甘油和重组人脑利钠肽对急性失代偿性心力衰竭的疗效比较.南方医科大学学报，2008，28(5)：839-842.
[18]尤华彦，吴小庆.重组人脑利钠肽辅助治疗慢性充血性心力衰竭273例疗效观察.山东医药，2009，49(51)：69-70.
[19]马登峰，王晨，王文强.重组人脑利钠肽治疗急性心肌梗死合并并心衰疗效评价.中西医结合心脑血管病杂志，2010，8(7)：866-868.
[20]王志方,刘玲玲,刘志强.冻干重组人脑利钠肽治疗顽固性心力衰竭的疗效观察.中国医药导报，2010,5(24):61-62., http://www.100md.com(曹伟灵 陈曦宋芳)